Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Foot: full-pipeline trial registry
14 of 31 indexed Diabetic Foot trials are currently recruiting.
Corpus placement: #495 of 28,707 conditions by registered trial count.
31 US clinical trials · 14 currently recruiting · #495 of 28,707 conditions by registered trial count
Diabetic Foot: 31 US clinical trials tracked, 14 recruiting.
Diabetic Foot is the subject of 31 registered US clinical trials on ClinicalTrials.gov, 14 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Aroa Biosurgery Limited, running 2 of these trials.
Enrollment posture brief
Registry condition diabetic-foot
OPEN 14 | RECR 45% | LATE 4 | EARLY 3 | RANK #495 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Stage IV Lung Cancer AJCC v8 (45% recruiting · 82 trials)
Diabetic Foot lists 14 open slots (45% of 31 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Foot on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Foot is recruiting above its size-band peers.
14 of 31 indexed trials (45.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetic Foot trials is spread across many organizations.
Aroa Biosurgery Limited accounts for 2 of 31 trials (6.5%). 28 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetic Foot enrolment sits around 119 participants.
Median target enrolment is 119 among the 31 trials that report a genuine target (sentinel values excluded). 10 of those (32.3%) plan for fewer than 100 participants.
-
Diabetic Foot research is mostly interventional.
24 interventional and 7 observational studies make up this index (77.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
31 total, page 1 of 1
A Real-World Registry of Chronic Wounds and Ulcers
U.S. Wound Registry
NCT02280733
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
University of Michigan
NCT06104969
Effectiveness of Remote Foot Temperature Monitoring
VA Office of Research and Development
NCT05728411
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
BioLab Holdings
NCT07089602
Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
University of Pittsburgh
NCT05172089
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Tiger Biosciences
NCT06826339
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
StimLabs
NCT06449638
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
MiMedx Group
NCT06600724
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
Applied Biologics
NCT06564831
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
Johns Hopkins University
NCT05579743
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
Axolotl Biologix
NCT06550596
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Applied Biologics
NCT07159282
Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers
University of Southern California
NCT06487780
Adapting Lifestyle Offloading for DFUs
University of Southern California
NCT06278935
A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot
Medaxis
NCT04564443
CGM and DFU Healing Post-discharge
Emory University
NCT06054659
SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)
PolarityTE
NCT06140303
Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM
BioStem Technologies
NCT06565156
Wound Assessment Using Spectral Imaging US
SpectralMD
NCT05415683
Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)
VisionQuest Biomedical
NCT03069729
Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers
Aroa Biosurgery Limited
NCT06035536
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
Medical University of South Carolina
NCT02626156
Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs
RedDress
NCT04185558
Implementation of Telemedicine for Patient With Lower Extremity Wounds
University of California, Davis
NCT04440839
Matrion™ Decellularized Placental Membrane in Subjects With Diabetic Foot Ulcers
LifeNet Health
NCT05087758
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
US Biotest
NCT00796744
Monitoring Physiologic Parameters in Individuals With Diabetic Peripheral Neuropathy
Orpyx Medical Technologies
NCT05613556
The Association Between Unprotected Standing, Walking and Wound Healing in Diabetes
University of Arizona
NCT02233179
Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™
Aroa Biosurgery Limited
NCT06035523
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
Celularity Incorporated
NCT01859117
Study of Subjects With Diabetic Foot Ulcer (DFU)
GlaxoSmithKline
NCT03153007
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Foot records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Foot trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Foot page
31 registered trials, 14 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 14 Diabetic Foot trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Aroa Biosurgery Limited sponsors the most Diabetic Foot trials on record, review their full trial history before evaluating a specific study. See Aroa Biosurgery Limited's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Foot condition card totals 31 registered trials; most-linked intervention Standard of Care; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.